Clinical Trial Update: Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome [Phase 1]

View source ↗

Summary

An early-stage Phase 1 clinical trial evaluating topical ATR12-351 for adults with Netherton Syndrome, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Netherton Syndrome

Drugs mentioned

• ATR12-351

Snippet

Sponsor: Azitra Inc. | Conditions: Netherton Syndrome | Phase 1 | Status: RECRUITING